Tempo Therapeutics Wins $2.25M NIH Grant for MAP Wound Healing
Tempo Therapeutics has received a $2.25 million NIH grant to advance its MAP wound healing technology, a step toward new options for hard-to-heal wounds.
Topic
Nih Funding
Topic
Topic
Topic
Tempo Therapeutics has received a $2.25 million NIH grant to advance its MAP wound healing technology, a step toward new options for hard-to-heal wounds.